OUR PEOPLE
Education and Training
Duke University, Durham, NC, B.S. - 05/2004 Biology
University of Oxford, Oxford, UK, M.Sc - 08/2006 Immunology
Weill Cornell/ Rockefeller/ Sloan-Kettering Institute, New York, NY, MD-PhD - 05/2014 Medicine
Yale School of Medicine/Yale New Haven, New Haven, CT 06/2015 Internship
Brigham & Women's Hospital, Boston, MA 06/2021 Residency
Overview
Sandeep P. Kishore is on faculty at the University of California, San Francisco (UCSF). Previously, he was on faculty at the Icahn School of Medicine at Mount Sinai.
His duties include leading a team dedicated to chronic disease prevention and control, directing initiatives at the health system level focused on the science and delivery of striving towards cardiovascular health equity - including formulating policy recommendations and scalable treatment guidelines. His portfolio focuses on enabling global access to essential medicines, developing technology-based solutions, and overcoming obstacles for access to essential treatments. His career is focused on delivering and evaluating population-level approaches for priority chronic conditions at scale. He and team members have worked to modernize the Essential Medicines List of the World Health Organization for cardiovascular, diabetes and mental illness treatments.
He is the founder and president of the Young Professionals Chronic Disease Network. He has focused on focusing the network of young health professionals on designing and delivering technical packages focused on essential medicines. He served as a consultant for Resolve to Save Lives, focused on global access to essential anti-hypertensive medications.
He has written extensively on responses to the global non-communicable disease epidemic in The Lancet, Health Affairs, Bulletin of WHO as well as Scientific American. He is a fellow of the New York Academy of Medicine, a term-member of the Council on Foreign Relations, an Emerging Leader for the National Academy of Medicine and recipient of the Paul & Daisy Soros Fellowship for New Americans.
He received an MD and PhD from the Weill Cornell/ Rockefeller/Sloan-Kettering Institute and was selected by his peers to deliver the commencement address and received most compassionate physician award. He received the Raymond W. Sarber Award for top American graduate student in microbiology for his work on anti-malarial laboratory research. He has held fellowships at Yale, Harvard and MIT and undertook clinical training at Yale and Brigham & Women's Hospital/Harvard Medical School.
His duties include leading a team dedicated to chronic disease prevention and control, directing initiatives at the health system level focused on the science and delivery of striving towards cardiovascular health equity - including formulating policy recommendations and scalable treatment guidelines. His portfolio focuses on enabling global access to essential medicines, developing technology-based solutions, and overcoming obstacles for access to essential treatments. His career is focused on delivering and evaluating population-level approaches for priority chronic conditions at scale. He and team members have worked to modernize the Essential Medicines List of the World Health Organization for cardiovascular, diabetes and mental illness treatments.
He is the founder and president of the Young Professionals Chronic Disease Network. He has focused on focusing the network of young health professionals on designing and delivering technical packages focused on essential medicines. He served as a consultant for Resolve to Save Lives, focused on global access to essential anti-hypertensive medications.
He has written extensively on responses to the global non-communicable disease epidemic in The Lancet, Health Affairs, Bulletin of WHO as well as Scientific American. He is a fellow of the New York Academy of Medicine, a term-member of the Council on Foreign Relations, an Emerging Leader for the National Academy of Medicine and recipient of the Paul & Daisy Soros Fellowship for New Americans.
He received an MD and PhD from the Weill Cornell/ Rockefeller/Sloan-Kettering Institute and was selected by his peers to deliver the commencement address and received most compassionate physician award. He received the Raymond W. Sarber Award for top American graduate student in microbiology for his work on anti-malarial laboratory research. He has held fellowships at Yale, Harvard and MIT and undertook clinical training at Yale and Brigham & Women's Hospital/Harvard Medical School.